← Back to Search

PCORI Pulse for Coronavirus

N/A
Waitlist Available
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
patients with suspected or confirmed COVID-19 started on COVID Watch as routine care via (1) outpatient COVID-19 testing or (2) who were tested for COVID-19 and discharged from the ED.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0, 7, and 14 days
Awards & highlights

Study Summary

This trial found that the use of text messaging and phone calls improved healthcare access for communities of color.

Eligible Conditions
  • Coronavirus

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0, 7, and 14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0, 7, and 14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Difference in Days Alive and Out of Hospital
Other outcome measures
Days Alive and Out of Hospital (DAOH) by Racial/Ethnic Subgroups Among COVID-19 Positive Patients
Days Between Program Enrollment and Home Pulse Oximetry Initiation
Health Care Utilization (Outpatient, Emergency Department, and Inpatient Care)
+12 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PCORI PulseExperimental Treatment2 Interventions
This arm is COVID Watch + pulse oximeter device. Patients sent a pulse oximeter will be prompted twice daily to text their oxygen saturation level after walking in place for 1 minute. If the oxygen saturation is >3% lower than than the baseline first O2 sat measurement, or if it falls below an absolute level of 90%, the patient will receive an immediate call from the same on-call RN's for COVID Watch and undergo the same triage protocol .
Group II: COVID WatchActive Control1 Intervention
COVID Watch provides text-based assessments, two times a day for 14 days and escalates care to a nurse via telemedicine for any reported worsening of symptoms not severe enough to recommend going to the ED immediately. This service is provided free of charge to patients, a benefit to patients without insurance or established primary care. UPHS already offers a version of COVID Watch with pulse oximetry to patients with COVID-19 being discharged from the ED who meet specific criteria: a discharge pulse ox less than 95%, an infiltrate on chest x-ray, are or age of 60 years or older, or who are deemed by the ED clinician to have significant comorbid conditions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
pulse oximeter
2020
N/A
~2510

Find a Location

Who is running the clinical trial?

Patient-Centered Outcomes Research InstituteOTHER
548 Previous Clinical Trials
29,994,239 Total Patients Enrolled
University of PennsylvaniaLead Sponsor
1,998 Previous Clinical Trials
42,877,284 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
COVID-19 Watch + COVID-19 Pulse
2020. "COVID-19 Watch + COVID-19 Pulse". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04581863.
~484 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top